Peptides

[(tert-butoxycarbonyl)amino](3-chlorophenyl)acetic acid is a Glycine (HY-Y0966) derivative.

(R)-Ethyl 2-amino-4-phenylbutanoate hydrochloride is a phenylalanine derivative.

N-(4-Cyanophenyl)glycine is a Glycine (HY-Y0966) derivative.

Boc-Ala-NMe(OMe) is an alanine derivative.

N-(tert-Butoxycarbonyl)-S-butylhomocysteine is a cysteine derivative.

α-Cyclobutylglycine is a Glycine (HY-Y0966) derivative.

N-(tert-Butoxycarbonyl)-O-(tert-butyl)-L-threonyl-L-proline is a proline derivative.

(R)-2-Amino-2-(tetrahydro-2H-pyran-4-yl)acetic acid is a Glycine (HY-Y0966) derivative.

N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N5,N5-dimethyl-L-glutamine is a glutamine derivative.

(S)-2-Amino-2-(tetrahydro-2H-pyran-4-yl)ethanoic acid is a Glycine (HY-Y0966) derivative.

(R)-2-amino-3-cyclobutylpropanoic acid is an alanine derivative.

α-Methyltyrosine methyl ester hydrochloride is a competitive tyrosine hydroxylase inhibitor that inhibits the conversion of tyrosine to dopamine. α-Methyltyrosine methyl ester hydrochloride can be used as a tool for sympathetic nervous system research.

(S)-methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate is a phenylalanine derivative.

LQVTDSGLYRCVIYHPP (LP17) TFA is a triggering receptor expressed on myeloid cells (TREM-1) inhibitory peptide. LQVTDSGLYRCVIYHPP TFA substantially alleviates ischemia-induced infarction and neuronal injury. LQVTDSGLYRCVIYHPP TFA can get access into brain and block TREM-1.

(Arg)9 (Nona-L-arginine) acetate is a cell-penetrating peptide (CPP) made up of 9 arginine residues. (Arg)9 acetate has neuroprotective property, exhibits neuroprotective activity with an IC50 of 0.78 μM in the glutamic acid model.

TDSRCVIGLYHPPLQVY TFA is a disordered control peptide. TDSRCVIGLYHPPLQVY TFA is a peptide containing the same amino acids as LP17 (HY-P3400) but in a different sequence order.

LQVTDSGLYRCVIYHPP is a myeloid cell triggered receptor 1 (TREM-1) inhibitory peptide .

Vitronectin (367-378) is a peptide corresponding to residues 367-378 of Vitronectin. Vitronectin is a multifunctional glycoprotein known in several human tumors for its adhesive role in processes such as cell growth, angiogenesis and metastasis.

Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin.

Boc-Lys(Z)-OH (DCHA) is a involves in synthesis thymosin β4, βg and β6 fragments, and increases E-rosette forming capacity in Lupus Nephritis model. Boc-Lys(Z)-OH (DCHA) involves in synthesis Boc-Lyz-OCH3 and acts as a reagent of peptidyl thrombin inhibitors production.

N-Benzoyl-DL-phenylalanine 2-Naphthyl Ester is a phenylalanine derivative.

N-Butyryl-DL-homocysteine thiolactone is an N-acyl homoserine lactone (AHL) analogue. AHLs are potent inhibitors of biofilm formation and virulence factors, and has been used for degrading microbial communities, reducing bacterial pathogenicity.

((3-Chlorophenyl)sulfonyl)proline is a proline derivative containing amino and carboxyl groups.

(S)-Boc-2-amino-5-azido-pentanoic acid (dicyclohexylammonium) is an amino acid derivative, can be used for the synthesis of compounds.